This study contributes to the expanding pool of evidence that reinforces the crucial involvement of TACE and TNF‐α in the transition from MASH to HCC, mediated by AATF, underscoring the potential of TACE as a therapeutic target to impede tumorigenesis. This evidence concerns the gene TNF and hepatocellular carcinoma.